Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$94,113
+$7,118 QoQ
Shares Held
374
-6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#4,024
of 4,150 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WealthCollab, LLC holds $2,747,050 across 15 Drug Manufacturers - General names. ABBV ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,910 | $993,022 | |
| 2 | LLY |
ELI LILLY & Co
|
756 | $906,769 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,673 | $214,980 | |
| 4 | PFE |
Pfizer Inc
|
5,017 | $120,808 | |
| 5 | NVS |
Novartis AG
|
692 | $108,450 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
374 | $94,113 | |
| 7 | GSK |
GSK plc
|
1,415 | $74,173 | |
| 8 | SNY |
Sanofi
|
1,469 | $62,667 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,113 | 374 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $86,995 | 400 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $91,395 | 400 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $92,847 | 401 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $66,637 | 359 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $73,960 | 353 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $61,839 | 348 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $43,444 | 220 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,080 | 257 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $46,799 | 257 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $38,121 | 246 | Shares | Sole | 2024-04-03 | |
| No filing history on record for this holder in this stock. | ||||||